Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript

Whether through the new platform, our existing and successful centralized laboratory vertical or even by providing PCR tools for vector control services to be more efficient and effective, our mission remains the same, preserving life by reducing the spread of infection disease and making our robust gold standard real time PCR testing solutions available to as many people and as many places as possible. Thank you to our shareholders as well as to the whole Co-Dx family of employees, distributors and consultants for joining us in this broad and significant undertaking. We look forward to talking with you again after the next quarter.

Operator: The conference has now concluded. Thank you very much for attending today’s presentation. You may now disconnect your lines.